Pharma Flash - Curia Expands its mRNA Capabilities; AWS to Be Used for Pharma AI and more news in the Pharma Flash | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services

Wednesday, August 2, 2023

1. Warfarin Reversal Drug Balfaxar® Receives FDA Approval For Urgent Procedures

2. FDA Approves First Treatment for Molluscum Contagiosum

3. Amneal Submits ANDAs to FDA for Three Key Complex Generics

4. EVERSANA and Amazon Web Services to “Pharmatize” AI Across the Life Sciences Industry

5. Curia Expands Biologics Capabilities With Access to Touchlight’s Doggybone DNA

2026 Company Focus & Industry Reference Guide
View Issue

Subscriptions

Get started here for yourcomplimentary print ordigital subscription

Get started here for your complimentary magazine subscription

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.